Summary

Market Overview
The global Cell Lysis Market is projected for substantial growth, expanding from USD 3.34 Billion in 2025 to USD 5.31 Billion by 2031, demonstrating an 8.03% CAgR. Cell lysis, defined as the essential process of rupturing cell membranes to liberate intracellular components like DNA, RNA, and proteins, is a foundational step for critical advancements in molecular biology, genomics, and proteomics research. Key drivers for this market expansion include the increasing global demand for biopharmaceuticals and the rapid evolution of precision medicine, both requiring high-quality sample extraction for subsequent analysis. Furthermore, the rising incidence of infectious and chronic diseases fuels the demand for robust diagnostic assays. This growth is underpinned by significant industry investment in innovation, as evidenced by the European pharmaceutical sector's estimated ?55 billion R&D expenditure in Europe during the year preceding 2025. Despite this positive outlook, the market faces challenges, particularly the high cost and technical complexity of advanced automated lysis instrumentation, which can impede widespread adoption by smaller research facilities. Additionally, the diverse nature of biological samples presents technical hurdles in standardizing protocols, potentially leading to inconsistent experimental outcomes.
Market Driver
The primary catalyst driving the global Cell Lysis Market is the escalating worldwide prevalence of chronic and infectious diseases, which mandates more robust diagnostic and research workflows. The growing burden of conditions like cancer, projected to exceed 2 million new cases in the U.S. in 2025, intensifies the need for molecular diagnostics and biomarker discovery?processes heavily reliant on efficient cell lysis for extracting high-quality genetic material and proteins. This trend compels clinical laboratories to increase their consumption of lysis reagents to manage the expanding volume of samples for precision oncology. Concurrently, a significant financial impetus comes from increased public and private funding in life sciences research. government allocations, such as the U.S. Congress enacting approximately $48.5 billion for the National Institutes of Health in fiscal year 2025, provide crucial capital for academic and commercial entities to acquire sophisticated sample preparation instrumentation. This funding supports the broader ecosystem of life science tools, as reflected by Thermo Fisher Scientific's 2024 revenue of $42.88 billion, underscoring the strong demand for laboratory products essential for downstream analyses.
Market Challenge
The global Cell Lysis Market faces a significant obstacle in the high cost and intricate technical nature of advanced automated lysis instrumentation. While large pharmaceutical corporations can absorb these substantial expenses, smaller academic and emerging research facilities frequently lack the necessary capital for high-throughput systems, thus limiting the widespread adoption of automated solutions. This economic disparity forces many smaller institutions to continue using manual, labor-intensive methods that offer lower throughput, creating an adoption gap where advanced technology remains inaccessible to a substantial segment of potential users and hinders broader market penetration. Compounding this issue is a challenging funding environment for smaller entities, with constrained financial resources preventing crucial upgrades to laboratory infrastructure. For example, biotech startup funding saw a significant decline from $2.6 billion to $900 million between Q1 and Q2 2025. This financial pressure, coupled with the technical difficulties of standardizing protocols across varied sample types, results in inconsistent operational efficiencies and ultimately dampens the market's overall growth trajectory.
Market Trends
Two pivotal trends are currently reshaping the global Cell Lysis Market. First, advancements in Single-Cell Lysis for Multi-Omics Analysis are driving a shift from bulk tissue processing to the precise extraction of intracellular contents from individual cells. This evolution is vital for unraveling cellular heterogeneity in fields such as oncology and immunology, demanding specialized, gentle lysis protocols that protect minute quantities of RNA and protein from degradation. The increasing adoption of these high-resolution workflows has spurred a dedicated segment for microfluidic and droplet-based lysis technologies, crucial for upstream sample preparation in multi-omics studies. The commercial impact of this shift is evident in 10x genomics' full-year 2024 revenue of $610.8 million, reflecting sustained industrial demand for single-cell platforms reliant on these advanced lysis methods. Second, the proliferation of Automated High-Throughput Lysis Systems is transforming laboratories by replacing manual disruption techniques with standardized, robotic platforms designed to enhance reproducibility and processing speed. As biobanks and clinical research centers manage growing sample volumes, there is a clear migration toward automated instruments that integrate lysis, binding, and washing steps into seamless "walk-away" protocols, thereby minimizing human error and cross-contamination. This transition is accelerating the installation of dedicated sample preparation units capable of processing diverse matrices, from blood to tissue. Qiagen's achievement of over 1,000 placements of its EZ2 Connect automated sample preparation instrument validates the robust market uptake of integrated lysis automation solutions.

Key Market Players
* Becton, Dickinson and Company
* Bio-Rad Laboratories Inc.
* Danaher Corporation
* Eppendorf Ag
* Hoffmann-La Roche Ltd
* Labfreez Instruments group Co. Ltd
* Merck KgaA
* Qsonica LLC
* Takara Bio Inc.
* Thermo Fisher Scientific Inc.

Report Scope
In this report, the global Cell Lysis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

# Cell Lysis Market, By Type of Product
* Instruments
* Reagents
# Cell Lysis Market, By Type of cells
* Mammalian Cells
* Microbial Cells
* Plant Cells
# Cell Lysis Market, By End user
* Biotechnology or Biopharmaceutical Companies
* Research Laboratories and Academic Institutes
* Other End Users
# Cell Lysis Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the global Cell Lysis Market.
Available Customizations:
global Cell Lysis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. global Cell Lysis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type of Product (Instruments {Homogeniser, Centrifugation, Other Types of Products}, Reagents)
5.2.2. By Type of cells (Mammalian Cells, Microbial Cells, Plant Cells)
5.2.3. By End user (Biotechnology or Biopharmaceutical Companies, Research Laboratories and Academic Institutes, Other End Users)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Cell Lysis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type of Product
6.2.2. By Type of cells
6.2.3. By End user
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Cell Lysis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type of Product
6.3.1.2.2. By Type of cells
6.3.1.2.3. By End user
6.3.2. Canada Cell Lysis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type of Product
6.3.2.2.2. By Type of cells
6.3.2.2.3. By End user
6.3.3. Mexico Cell Lysis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type of Product
6.3.3.2.2. By Type of cells
6.3.3.2.3. By End user
7. Europe Cell Lysis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type of Product
7.2.2. By Type of cells
7.2.3. By End user
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. germany Cell Lysis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Product
7.3.1.2.2. By Type of cells
7.3.1.2.3. By End user
7.3.2. France Cell Lysis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Product
7.3.2.2.2. By Type of cells
7.3.2.2.3. By End user
7.3.3. United Kingdom Cell Lysis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Product
7.3.3.2.2. By Type of cells
7.3.3.2.3. By End user
7.3.4. Italy Cell Lysis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Product
7.3.4.2.2. By Type of cells
7.3.4.2.3. By End user
7.3.5. Spain Cell Lysis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Product
7.3.5.2.2. By Type of cells
7.3.5.2.3. By End user
8. Asia Pacific Cell Lysis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type of Product
8.2.2. By Type of cells
8.2.3. By End user
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Cell Lysis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Product
8.3.1.2.2. By Type of cells
8.3.1.2.3. By End user
8.3.2. India Cell Lysis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type of Product
8.3.2.2.2. By Type of cells
8.3.2.2.3. By End user
8.3.3. Japan Cell Lysis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Product
8.3.3.2.2. By Type of cells
8.3.3.2.3. By End user
8.3.4. South Korea Cell Lysis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Product
8.3.4.2.2. By Type of cells
8.3.4.2.3. By End user
8.3.5. Australia Cell Lysis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Product
8.3.5.2.2. By Type of cells
8.3.5.2.3. By End user
9. Middle East & Africa Cell Lysis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type of Product
9.2.2. By Type of cells
9.2.3. By End user
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Cell Lysis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Product
9.3.1.2.2. By Type of cells
9.3.1.2.3. By End user
9.3.2. UAE Cell Lysis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Product
9.3.2.2.2. By Type of cells
9.3.2.2.3. By End user
9.3.3. South Africa Cell Lysis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Product
9.3.3.2.2. By Type of cells
9.3.3.2.3. By End user
10. South America Cell Lysis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type of Product
10.2.2. By Type of cells
10.2.3. By End user
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cell Lysis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Product
10.3.1.2.2. By Type of cells
10.3.1.2.3. By End user
10.3.2. Colombia Cell Lysis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Product
10.3.2.2.2. By Type of cells
10.3.2.2.3. By End user
10.3.3. Argentina Cell Lysis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Product
10.3.3.2.2. By Type of cells
10.3.3.2.3. By End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. global Cell Lysis Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Becton, Dickinson and Company
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Bio-Rad Laboratories Inc.
15.3. Danaher Corporation
15.4. Eppendorf Ag
15.5. Hoffmann-La Roche Ltd
15.6. Labfreez Instruments group Co. Ltd
15.7. Merck KgaA
15.8. Qsonica LLC
15.9. Takara Bio Inc.
15.10. Thermo Fisher Scientific Inc.
16. Strategic Recommendations
17. About Us & Disclaimer